Clinical Trial Update: Infliximab Top-down in Pediatric Crohn [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating top-down infliximab in pediatric Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED